Arthritis Completed Phase 3 Trials for Adalimumab (DB00051)

Also known as: Articular inflammation / Unspecified osteoarthritis, unspecified site / Inflammatory arthritis / Arthritis (disorder) / Arthritis NOS

IndicationStatusPhase
DBCOND0016433 (Arthritis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00646178Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug TherapyTreatment